Driehaus Capital Management LLC

Source: SEC Form 13F · as of Mar 2026

Driehaus Capital Management LLC holds 73 biotech & pharma companies tracked by BioSniper, totaling $3.40B in value as of Mar 2026 (SEC Form 13F).

Companies held

73

Total value held

$3.40B

CompanySharesValue
PRAXPraxis Precision Medicines, Inc.949,225$305.8M
XENEXenon Pharmaceuticals Inc.4,491,653$261.2M
CRNXCrinetics Pharmaceuticals, Inc.6,395,922$232.3M
APGEApogee Therapeutics, Inc.1,920,800$161.7M
EWTXEdgewise Therapeutics, Inc.4,477,942$141.1M
GHGuardant Health Inc.1,524,282$140.8M
SYRESpyre Therapeutics, Inc.2,790,785$140.8M
DFTXDefinium Therapeutics Inc.5,911,889$111.7M
SEPNSepterna, Inc.4,395,572$105.6M
SRRKScholar Rock Holding Corp1,920,233$94.4M
IMNMImmunome Inc.4,099,901$89.7M
KYMRKymera Therapeutics, Inc.1,043,583$86.9M
BBIOBridgeBio Pharma, Inc.1,146,671$85.2M
GPCRStructure Therapeutics Inc.1,577,356$76.0M
PTGXProtagonist Therapeutics, Inc720,928$76.0M
ARWRARROWHEAD PHARMACEUTICALS, INC.1,190,335$74.6M
PTCTPTC THERAPEUTICS, INC.1,015,772$69.2M
CGONCG Oncology, Inc.999,623$67.7M
TARSTarsus Pharmaceuticals, Inc.926,125$65.0M
MDGLMADRIGAL PHARMACEUTICALS, INC.110,960$58.1M
INDVIndivior Pharmaceuticals, Inc.1,880,039$57.3M
ARQTArcutis Biotherapeutics, Inc.2,226,029$52.4M
AXSMAxsome Therapeutics, Inc.292,370$49.4M
NUVLNuvalent, Inc.481,180$49.3M
ONCBeOne Medicines Ltd.155,002$46.0M
AMLXAmylyx Pharmaceuticals, Inc.2,987,147$41.5M
WVEWave Life Sciences Ltd.5,431,021$39.4M
TVTXTravere Therapeutics, Inc.1,282,518$38.1M
RYTMRHYTHM PHARMACEUTICALS, INC.436,546$38.0M
DRUGBRIGHT MINDS BIOSCIENCES INC.432,515$31.6M
MBXMBX Biosciences, Inc.1,018,212$30.4M
KNSAKiniksa Pharmaceuticals International, plc611,398$29.4M
ASNDAscendis Pharma A/S127,562$29.2M
ALKSAlkermes plc.791,963$28.0M
TWSTTwist Bioscience Corp584,696$27.8M
DNTHDianthus Therapeutics, Inc. /DE/317,312$26.6M
ADPTAdaptive Biotechnologies Corp1,750,601$24.3M
LGNDLigand Pharmaceuticals Incorporated118,169$23.6M
ALNYALNYLAM PHARMACEUTICALS, INC.59,622$19.7M
NPCENeuropace Inc.1,451,611$19.1M
MAZEMaze Therapeutics, Inc.636,162$19.0M
DSGNDesign Therapeutics, Inc.1,744,987$18.6M
INSMINSMED Inc105,414$17.2M
RLMDRELMADA THERAPEUTICS, INC.2,132,053$14.8M
GMEDGlobus Medical Inc.167,468$14.4M
ABCLAbCellera Biologics Inc.4,024,779$14.0M
LRMRLarimar Therapeutics, Inc.2,934,399$13.2M
NEONeoGenomics Inc.1,721,750$12.8M
INCYIncyte Corp.128,144$12.1M
ALXOALX ONCOLOGY HOLDINGS INC5,734,620$11.5M
KALVKalVista Pharmaceuticals, Inc.564,039$11.4M
IVVDInvivyd, Inc.8,436,894$11.0M
ANROAlto Neuroscience, Inc.486,726$10.9M
ANIPANI PHARMACEUTICALS INC121,459$9.3M
JBIOJade Biosciences, Inc.635,498$8.9M
KMTSKestra Medical Technologies Ltd.447,315$8.9M
ELANElanco Animal Health Inc344,171$8.2M
DTILPRECISION BIOSCIENCES INC995,371$5.5M
XERSXeris Biopharma Holdings, Inc.902,740$5.2M
KRROKorro Bio, Inc.450,045$5.1M
CLYMClimb Bio, Inc.600,946$4.1M
SIONSionna Therapeutics, Inc.76,633$3.1M
PGENPRECIGEN, INC.793,773$3.1M
PTNPALATIN TECHNOLOGIES INC166,713$2.9M
AKTSAktis Oncology Inc.150,000$2.7M
MNPRMonopar Therapeutics33,156$1.8M
LLYELI LILLY & Co1,168$1.1M
AZNASTRAZENECA PLC3,967$782K
NGNENeurogene Inc.32,765$661K
GILDGILEAD SCIENCES, INC.4,085$569K
MRKMerck & Co., Inc.4,287$516K
PEPGPepGen Inc.279,909$495K
ABBVAbbVie Inc.2,039$443K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Driehaus Capital Management LLC — Biotech 13F Holdings & Portfolio | BioSniper